Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 7963895, 7 pages
http://dx.doi.org/10.1155/2016/7963895
Research Article

The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer

1Department of Biochemical Diagnostics, Medical University, Waszyngtona 15A, 15-269 Białystok, Poland
2Department of Biochemical Diagnostics, University Hospital, Waszyngtona 15A, 15-269 Białystok, Poland
3Department of Neurodegeneration Diagnostics, Medical University, Waszyngtona 15A, 15-269 Białystok, Poland
4Department of Thoracic Surgery, Medical University, Marii Skłodowskiej-Curie 24A, 15-276 Białystok, Poland

Received 28 October 2015; Accepted 8 February 2016

Academic Editor: Ralf Lichtinghagen

Copyright © 2016 Marta Łukaszewicz-Zając et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Raman, P. J. Baugher, Y. M. Thu, and A. Richmond, “Role of chemokines in tumor growth,” Cancer Letters, vol. 256, no. 2, pp. 137–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Shrivastava, Z. Hussain, O. Giricz et al., “Targeting chemokine pathways in esophageal adenocarcinoma,” Cell Cycle, vol. 13, no. 21, pp. 3320–3327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Rot and U. H. von Andrian, “Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells,” Annual Review of Immunology, vol. 22, pp. 891–928, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Ransohoff, “Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology,” Immunity, vol. 31, no. 5, pp. 711–721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Domper Arnal, Á. Ferrández Arenas, and Á. Lanas Arbeloa, “Esophageal cancer: risk factors, screening and endoscopic treatment in western and eastern countries,” World Journal of Gastroenterology, vol. 21, pp. 7933–7943, 2015. View at Google Scholar
  6. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: A Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. D. Crew and A. I. Neugut, “Epidemiology of upper gastrointestinal malignancies,” Seminars in Oncology, vol. 31, no. 4, pp. 450–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Pohl and H. G. Welch, “The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence,” Journal of the National Cancer Institute, vol. 97, no. 2, pp. 142–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Arnold, I. Soerjomataram, J. Ferlay, and D. Forman, “Global incidence of oesophageal cancer by histological subtype in 2012,” Gut, vol. 64, no. 3, pp. 381–387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Holmes and T. L. Vaughan, “Epidemiology and pathogenesis of esophageal cancer,” Seminars in Radiation Oncology, vol. 17, no. 1, pp. 2–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lao-Sirieix and R. C. Fitzgerald, “Screening for oesophageal cancer,” Nature Reviews Clinical Oncology, vol. 9, no. 5, pp. 278–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. R. Lundell, “Etiology and risk factors for esophageal carcinoma,” Digestive Diseases, vol. 28, no. 4-5, pp. 641–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. T. Mayne and S. A. Navarro, “Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans,” Journal of Nutrition, vol. 132, no. 11, pp. 3467S–3470S, 2002. View at Google Scholar · View at Scopus
  14. S. Motoyama, M. Miura, Y. Hinai et al., “CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer,” Annals of Surgical Oncology, vol. 16, no. 9, pp. 2479–2485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sasaki, S. Natsugoe, S. Ishigami et al., “Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma,” Oncology Reports, vol. 21, no. 1, pp. 65–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. F. Wang, N. Lou, C. G. Zeng, X. Zhang, and F. J. Chen, “Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma,” Ai Zheng, vol. 28, no. 2, pp. 154–158, 2009. View at Google Scholar
  17. J. T. Kaifi, E. F. Yekebas, P. Schurr et al., “Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer,” Journal of the National Cancer Institute, vol. 97, no. 24, pp. 1840–1847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Lu, Y. Ji, D. Ge, J. Guo, and J. Y. Ding, “The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer,” Diseases of the Esophagus, vol. 24, no. 4, pp. 283–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Łukaszewicz-Zając, B. Mroczko, and M. Szmitkowski, “Chemokines and their receptors in esophageal cance—the systematic review and future perspectives,” Tumor Biology, vol. 36, no. 8, pp. 5707–5714, 2015. View at Publisher · View at Google Scholar
  20. J. R. Jass and L. H. Sobin, “Histological typing of intestinal tumors,” in WHO International Histological Classification of Tumors, Springer, New York, NY, USA, 1989. View at Google Scholar
  21. M. Łukaszewicz-Zając, B. Mroczko, M. Kozłowski et al., “Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus),” Journal of Clinical Laboratory Analysis, vol. 26, no. 2, pp. 73–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Łukaszewicz-Zając, B. Mroczko, M. Kozłowski, J. Nikliński, J. Laudański, and M. Szmitkowski, “Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 10, pp. 1467–1473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. łukaszewicz-Zajac, B. Mroczko, M. Kozłowski, J. Nikliński, J. Laudański, and M. Szmitkowski, “Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients,” Diseases of the Esophagus, vol. 25, no. 3, pp. 242–249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Mroczko, M. Kozłowski, M. Groblewska et al., “The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients,” Clinica Chimica Acta, vol. 389, no. 1-2, pp. 61–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska et al., “Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas—implication for clinical evaluation of cancer patient,” Cytokine, vol. 41, no. 3, pp. 232–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Gockel, C. C. Schimanski, C. Heinrich et al., “Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma,” BMC Cancer, vol. 6, article 290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Zamanian-Azodi, M. Rezaei-Tavirani, H. Hasanzadeh et al., “Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach,” Gastroenterology and Hepatology from Bed to Bench, vol. 8, no. 1, pp. 6–18, 2015. View at Google Scholar · View at Scopus
  28. J. Zhang, Z. Zhu, Y. Liu et al., “Diagnostic value of multiple tumor markers for patients with esophageal carcinoma,” PLoS ONE, vol. 10, no. 2, Article ID e0116951, 2015. View at Publisher · View at Google Scholar
  29. S. Ławicki, G. E. Będkowska, E. Gacuta-Szumarska, and M. Szmitkowski, “The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors,” Journal of Ovarian Research, vol. 6, article 45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. B. R. Keeley, F. Islami, A. Pourshams et al., “Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer,” Cancer Science, vol. 105, no. 9, pp. 1205–1211, 2014. View at Publisher · View at Google Scholar · View at Scopus